Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Cost of Revenue: 2019-2025

Historic Cost of Revenue for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to $4.1 million.

  • Biodesix's Cost of Revenue fell 1.75% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.2 million, marking a year-over-year increase of 10.80%. This contributed to the annual value of $15.6 million for FY2024, which is 19.70% up from last year.
  • According to the latest figures from Q3 2025, Biodesix's Cost of Revenue is $4.1 million, which was up 1.86% from $4.0 million recorded in Q2 2025.
  • Over the past 5 years, Biodesix's Cost of Revenue peaked at $18.2 million during Q1 2021, and registered a low of $2.5 million during Q4 2021.
  • For the 3-year period, Biodesix's Cost of Revenue averaged around $3.7 million, with its median value being $3.7 million (2025).
  • Data for Biodesix's Cost of Revenue shows a peak YoY increase of 1,052.31% (in 2021) and a maximum YoY decrease of 82.99% (in 2021) over the last 5 years.
  • Over the past 5 years, Biodesix's Cost of Revenue (Quarterly) stood at $2.5 million in 2021, then skyrocketed by 32.61% to $3.3 million in 2022, then climbed by 2.06% to $3.4 million in 2023, then increased by 28.69% to $4.3 million in 2024, then decreased by 1.75% to $4.1 million in 2025.
  • Its Cost of Revenue stands at $4.1 million for Q3 2025, versus $4.0 million for Q2 2025 and $3.7 million for Q1 2025.